Teleologically, we suggest the simultaneous effects of IL-33 to permit myelopoiesis and suppress erythropoiesis could enable organisms to respond to transient damage or infection, taking advantage of the long circulating time of mature RBCs to provide a buffer against the development of anemia while BM output is diverted to meet other demands. Here, IL33 is linked to anemia (phenotype).